A major outbreak of severe acute respiratory syndrome in Hong Kong.

By N. Lee, D. Hui, A. Wu, P. Chan, P. Cameron, G. Joynt, A. Ahuja, M. Yung, C. Leung, K. To and 4 more. New England Journal of Medicine, 2003

2,340 citations recorded by the source corpus.

Subfields: Infectious Diseases, Neurology

View Paper: https://www.semanticscholar.org/paper/4b78bea398ef38893618f418223b10ad72bebe9c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

In Neurology

Citations in the corpus

Cell entry mechanisms of SARS-CoV-2 (2020, background): “These numbers dwarf the impact of the related SARS coronavirus (SARS-CoV), which caused about 8,000 infections and 800 deaths (3, 4).”
[Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. (2020, background): “20, 21 However, few patients with 2019-nCoV infection had prominent upper respiratory tract signs and symptoms (eg, rhinorrhoea, sneezing, or sore throat), indicating that the target cells might be located in the lower airway.”
A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics (2013, background): “These 2 peaks coincide with the occurrence of known superspreading events, the ﬁ rst occurring in weeks 3 and 4, and the second occurring between weeks 5 and 6 (16, 27, 28).”
From SARS to MERS, Thrusting Coronaviruses into the Spotlight (2019, background): “Additionally, the zoonotic transmission of SARS from December 2003 to January 2004 [6] provided insight for researchers into the origin of this novel coronavirus.”
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis (2018, result): “Consistently with what was observed in human SARS-CoV patients (25), lymphopenia was observed in the lungs of both SARS-CoV MA15-infected C57BL/6J and C3–/– mice with reduced percentages of B cells (Fig.”
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past (2020, background): “However, the aforementioned variables were not associated with the composite outcome of intensive care unit admission or death [30].”
Use of convalescent plasma therapy in SARS patients in Hong Kong (2004, background): “In Hong Kong, ribavirin and steroids have been used, and 74% of patients have recovered without requiring admission to the intensive care unit [4].”